The microbial polyketides market is projected to grow from USD 1,273.3 million in 2025 to USD 2,136.7 million by 2035, advancing at a CAGR of 5.3%. Active Pharmaceutical Ingredients (APIs) & Drug Products are expected to lead the market with a 77.3% share in 2025, while Pharmaceutical Companies are anticipated to account for 41.1% of the end user segment.